Computed Tomographic Imaging in Connective Tissue Diseases

ABSTRACT

The connective tissue diseases are a group of autoimmune mediated disorders characterized by multiorgan damage. High-resolution computed tomography (HRCT) plays an important role in identifying patients with respiratory involvement. Although there is some overlap, typical HRCT appearances are increasingly recognized for each of the major connective tissue diseases and are described in detail in this review (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, Sjögren syndrome, polymyositis/dermatomyositis, mixed connective tissue disease). The clinical utility of HRCT is discussed with respect to the detection of disease, diagnosis, staging of disease severity, prognostic evaluation, and monitoring of disease progression. The difficult problem of establishing the clinical significance of CT abnormalities is also addressed.

KEYWORDS

Computed tomography - imaging - connective tissue diseases

REFERENCES

• 1 Remy-Jardin M. Lung changes in rheumatoid arthritis: CT findings.  Radiology. 1994;  193 375-382
• 2 Terasaki H, Fujimoto K, Hayabuchi N et al.. Respiratory symptoms in rheumatoid arthritis: relation between high resolution CT findings and functional impairment.  Radiat Med. 2004;  22 179-185
• 3 Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses.  J Comput Assist Tomogr. 1999;  23 941-948
• 4 Tanaka N, Kim J S, Newell S D et al.. Rheumatoid arthritis-related lung diseases: CT findings.  Radiology. 2004;  232 81-91
• 5 Zrour S H, Touzi M, Bejia I et al.. Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis: prospective study in 75 patients.  Joint Bone Spine. 2005;  72 41-47
• 6 Katzenstein A L, Fiorelli R F. Nonspecific interstitial pneumonia/fibrosis: histologic features and clinical significance.  Am J Surg Pathol. 1994;  18 136-147
• 7 Turner-Warwick M, Evans R C. Pulmonary manifestations of rheumatoid disease.  Clin Rheum Dis. 1977;  3 549-564
• 8 Talbott J A, Calkins E. Pulmonary involvement in rheumatoid arthritis.  JAMA. 1964;  189 911-913
• 9 Ellis S J, Cleverley J R, Müller N L. Drug induced lung disease: high-resolution CT findings.  AJR Am J Roentgenol. 2000;  175 1019-1024
• 10 Arakawa H, Yamasaki M, Kurihara Y, Yamada H, Nakahima Y. Methotrexate induced pulmonary injury: serial CT findings.  J Thorac Imaging. 2003;  18 231-236
• 11 Murin S, Wiedemann H P, Matthay R A. Pulmonary manifestations of systemic lupus erythematosus.  Clin Chest Med. 1998;  19 641-665
• 12 Fenlon H M, Doran M, Sant S M, Breatnach E. High resolution CT in systemic lupus erythematosus.  AJR Am J Roentgenol. 1996;  166 301-307
• 13 Kim J S, Lee K S, Koh E, Kim S Y, Chung M P, Han J. Thoracic involvement of systemic lupus erythematosus: clinical, pathological and radiological findings.  J Comput Assist Tomogr. 2000;  24 9-18
• 14 Estes D, Christian C L. The natural history of systemic lupus erythematosus by prospective analysis.  Medicine. 1971;  50 85-94
• 15 Bankier A A, Kiener H P, Wiesmayr M N et al.. Discrete lung involvement in systemic lupus erythematosus: CT assessment.  Radiology. 1995;  196 835-840
• 16 Clause H P, Sanger P W, Taylor F H, Robicsek F. Systemic lupus erythematosus associated with bronchiectasis: report of two cases.  Dis Chest. 1964;  45 219-222
• 17 Devenyi K, Czirjak L. High-resolution computed tomography for the evaluation of lung involvement in 101 patients with scleroderma.  Clin Rheumatol. 1995;  14 633-640
• 18 Chan T Y, Hansell D M, Rubens M B et al.. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomography scans.  Thorax. 1997;  52 265-270
• 19 Desai S R, Veeraraghavan S, Hansell D M et al.. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.  Radiology. 2004;  232 560-567
• 20 Launay D, Remy-Jardin M, Michon-Pasturel U et al.. High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis.  J Rheumatol. 2006;  33 1789-1801
• 21 Coghlan J G, Handler C. Connective tissue associated pulmonary arterial hypertension.  Lupus. 2006;  15 138-142
• 22 Cailes J B, du Bois R M, Hansell D M. Density gradient of the lung parenchyma at computed tomography scanning in patients with pulmonary hypertension and systemic sclerosis.  Acad Radiol. 1996;  3 724-730
• 23 Bhalla M, Silver R M, Shepard J et al.. Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy.  AJR Am J Roentgenol. 1993;  161 269-272
• 24 Franquet T, Giminez A, Monill J M, Diaz C, Geli C. Primary Sjögren's syndrome and associated lung disease: CT findings in 50 patients.  AJR Am J Roentgenol. 1997;  169 655-658
• 25 Koyama M, Johoh T, Honda O et al.. Pulmonary involvement in primary Sjögren's syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients.  J Thorac Imaging. 2001;  16 290-296
• 26 Lohrmann C, Uhl M, Warnatz K et al.. High-resolution CT imaging of the lung for patients with primary Sjögren's syndrome.  Eur J Radiol. 2004;  52 137-143
• 27 Meyer C A, Pina J S, Taillon D et al.. Inspiratory and expiratory high resolution CT findings in a patient with Sjögren's syndrome and cystic lung disease.  AJR Am J Roentgenol. 1997;  168 101-103
• 28 Tonami H, Matoba M, Yokota H et al.. Mucosa associated lymphoid tissue lymphoma in Sjögren's syndrome: initial and follow-up imaging features.  AJR Am J Roentgenol. 2002;  179 485-489
• 29 Parambil J G, Myers J L, Lindell R M, Matteson E L, Ryu J H. Interstitial lung disease in primary Sjögren syndrome.  Chest. 2006;  130 1489-1495
• 30 Fathi M, Dastmalchi M, Rasmussen E, Lundberg I E, Tornling G. Interstitial lung disease: a common manifestation of newly diagnosed polymyositis and dermatomyositis.  Ann Rheum Dis. 2004;  63 297-301
• 31 Douglas W W, Tazelaar H D, Hartman T E et al.. Polymyositis-dermatomyositis associated interstitial lung disease.  Am J Respir Crit Care Med. 2001;  164 1182-1185
• 32 Arakawa H, Yamada H, Kuihara Y et al.. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high resolution CT findings and functional correlation.  Chest. 2003;  123 1096-1103
• 33 Akira M, Hara H, Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: long term follow up CT evaluation in seven patients.  Radiology. 1999;  210 333-338
• 34 Mino M, Noma S, Taguchi Y et al.. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: sequential evaluation with CT.  AJR Am J Roentgenol. 1997;  169 83-87
• 35 Prakash U B. Respiratory complications in mixed connective tissue disease.  Clin Chest Med. 1998;  19 733-746
• 36 Kozuka T, Johkoh T, Honda O et al.. Pulmonary involvement in mixed connective tissue disease: high-resolution CT findings in 41 patients.  J Thorac Imaging. 2001;  16 94-98
• 37 Sullivan W D, Hurst D J, Harmon C E et al.. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective disease.  Medicine (Baltimore). 1984;  63 92-107
• 38 Bosch X, Guilabert A, Pallares L et al.. Infections in systemic lupus erythematosus: a prospective and controlled study of patients.  Lupus. 2006;  15 584-589
• 39 Peltomaa R, Paimela L, Kautiainen H, Leirisalo-Repo M. Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis.  Ann Rheum Dis. 2002;  61 889-894
• 40 Varoczy L, Gergely L, Margit Z, Gyula S, Illes A. Malignant lymphoma associated autoimmune disease: a descriptive epidemiological study.  Rheumatol Int. 2002;  22 233-237
• 41 Lewis E R, Caskey C I, Fishman E K. Lymphoma of the lung: CT findings in 31 patients.  AJR Am J Roentgenol. 1991;  156 711-714
• 42 Cervantes-Perez P, Toro-Perez A H, Rodriguez-Jurado P. Pulmonary involvement in rheumatoid arthritis.  JAMA. 1980;  243 1715-1719
• 43 Schurawitzki H, Stiglbauer R, Graninger W et al.. Interstitial lung disease in progressive systemic sclerosis: high resolution CT versus radiography.  Radiology. 1990;  176 755-759
• 44 Dawson J K, Fewins H E, Desmond J, Lynch M P, Graham D R. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests.  Thorax. 2001;  56 622-627
• 45 Orens J B, Kazerooni E A, Martinez F J et al.. The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy.  Chest. 1995;  108 109-115
• 46 Muller N L, Staples C A, Miller R R, Vedal S, Thurlbeck W M, Ostrow D N. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation.  Radiology. 1987;  165 731-734
• 47 Wells A U, Hansell D M, Rubens M B, Cullinan P, Black C M, du Bois R M. The predictive value of appearances on thin section computed tomography in fibrosing alveolitis.  Am Rev Respir Dis. 1993;  148 1076-1082
• 48 Wells A U, Hansell D M, Corrin B et al.. High resolution computed tomography as a predictor of lung histology in systemic sclerosis.  Thorax. 1992;  47 738-742
• 49 Wells A U, Rubens M B, du Bois R M, Hansell D M. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern.  AJR Am J Roentgenol. 1993;  161 1159-1165
• 50 Bouros D, Wells A U, Nicholson A G et al.. Histopathological subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.  Am J Respir Crit Care Med. 2002;  165 1581-1586
• 51 Remy-Jardin M, Giraud F, Remy J, Copin M C, Gosselin B, Duhamel A. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation.  Radiology. 1993;  189 693-698
• 52 Flaherty K R, Colby T V, Travis W D et al.. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease.  Am J Respir Crit Care Med. 2003;  167 1410-1415
• 53 Tashkin D P, Elashoff R, Clements P J for the Scleroderma Lung Study Research Group et al.. Cyclophosphamide versus placebo in scleroderma lung disease.  N Engl J Med. 2006;  354 2655-2666
• 54 Wells A U, Hansell D M, Rubens M B et al.. Fibrosing alveolitis in systemic sclerosis: bronchoalveolar lavage findings in relation to computed tomographic appearances.  Am J Respir Crit Care Med. 1994;  150 462-468
• 55 Goh N SL, Veeraraghavan S, Desai S R et al.. Bronchoalveolar lavage (BAL) cellular profiles in the interstitial lung disease of systemic sclerosis are not predictive of disease progression.  Arthritis Rheum. 2007;  56 2005-2012
• 56 Wells A U, Hansell D M, Rubens M B et al.. Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography.  Arthritis Rheum. 1997;  40 1229-1236